Logo

Comprehensive NTRK Fusion Detection, Agnostic of the Fusion Partner, for Optimal Identification of Rare Genomic Events

NTRK fusions are recently discovered biomarkers that play an important role in the response to TRK inhibitors. Comprehensive genomic profiling on all solid tumors permits detection of rare genomic events and, in the future, may change the way we approach cancer.


Accurate and comprehensive detection of NTRK fusions is difficult because NTRK genes include:

  • numerous potential fusion partners
  • large intronic regions
  • GC-rich content

Amongst the variable performance of NTRK fusion assays, NTRK detection from RNA using hybrid-capture next-generation sequencing provides comprehensive and accurate fusion detection, agnostic of the fusion partner.

View the webinar to learn more.


View the webinar to learn more

Country
Would you like to receive email marketing communications from Illumina?
This Offer Has Expired








By submitting this form, you agree to have your contact information passed along for the purpose of following up on your interests and in order to receive communications regarding Illumina products, services, and events. The data sent will be processed in Canada and provided to Illumina who will assume responsibility for processing and Opt-out and Information Removal. For more information, please read our Terms of Use, Privacy, Opt-out & Information Removal.